- Trials with a EudraCT protocol (44,352)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44,352 result(s) found.
Displaying page 2,104 of 2,218.
| EudraCT Number: 2010-021396-81 | Sponsor Protocol Number: LINES | Start Date*: 2011-06-15 |
| Sponsor Name:INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE DE VALENCIA | ||
| Full Title: European Low and Intermediate Risk Neuroblastoma | ||
| Medical condition: INTERMEDIATE AND LOW RISK NEUROBLASTOMA | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) DK (Completed) AT (Completed) IT (Completed) BE (Completed) NO (Completed) FR (Completed) IE (Completed) SE (Completed) PT (Completed) LT (Completed) GR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004679-11 | Sponsor Protocol Number: 0604 | Start Date*: 2020-04-21 |
| Sponsor Name:Division of Thoracic and Hyperbaric Surgery, Medical University Graz | ||
| Full Title: Hyperbaric Oxygenation (HBO) in traumatic spinal cord injury - prospective study with 100 patients. | ||
| Medical condition: We want to investigate the effect of hyperbaric oxygen therapy on the neurological and clinical outcome following traumatic injury of the spinal cord. | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-001806-94 | Sponsor Protocol Number: VACC-IR | Start Date*: 2006-05-22 |
| Sponsor Name:Hôpital Erasme | ||
| Full Title: Comparison of the efficacy of pneumococcal and tetanus vaccination between hemodialysis patients and renal tranpslant recipients treated with Mycophenolic acid(VACC-IR) study. | ||
| Medical condition: Patients on dialysis and waiting for renal transplant and renal translanted patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-017137-22 | Sponsor Protocol Number: 190178 | Start Date*: 2013-04-16 |
| Sponsor Name:Klinische Abteilung für Thorax -u. Hyperbare Chirurgie, Medizinische Universität Graz | ||
| Full Title: Clinical course after substitution of Vitamin-D deficiency in patients with lung cancer or oesophageal carcinoma. Double blind randomised prospective, placebo-controlled study. | ||
| Medical condition: Patients admitted for treatment on a general thoracic surgery division with the following conditions: Lung cancer Esophageal cancer Cancer of the gastroesophageal junction (GEJ) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002963-92 | Sponsor Protocol Number: CLRX712A12201 | Start Date*: 2020-02-05 | |||||||||||
| Sponsor Name:Novartis Pharma AG | |||||||||||||
| Full Title: A randomized, placebo-controlled, subject and investigator blinded study investigating the safety, tolerability and preliminary efficacy of 8-week treatment with intra-articular LRX712 to regenerat... | |||||||||||||
| Medical condition: Cartilage injuries | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) AT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2007-005399-15 | Sponsor Protocol Number: CEFFOS7 | Start Date*: 2010-03-10 |
| Sponsor Name:Medizinische Universität Graz - Abteilung für Thorax- und Hyperbare Chirurgie | ||
| Full Title: Penetration of Cubicin® and Fosfomycin® into skeletal muscle and subcutaneous adipose tissue of necrotizing soft tissue infections, measured by in-vivo microdialysis | ||
| Medical condition: A group of adult male or female patients with documented necrotizing soft tissue infection who must be subjected to undergo intravenous antimicrobial therapy with broad spectrum antibiotics. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-020939-40 | Sponsor Protocol Number: MD-Neo-Pilot | Start Date*: 2010-07-28 |
| Sponsor Name:Medizinische Universität Wien,Univ.Klinik f.Kinder-u.Jugendheilkunde | ||
| Full Title: Pilot Trial: Feasibility of Microdialysis for Pharmacokinetic Studies in Neonatal Patients | ||
| Medical condition: The present pilot study intends to establish the logistics of MD measurements of antibiotics in subcutaneous tissue of neonatal intensive care patients. Antibiotic serum levels will be measured in ... | ||
| Disease: | ||
| Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-001271-38 | Sponsor Protocol Number: LT 2004 09 | Start Date*: 2006-06-23 |
| Sponsor Name:Our Lady's Hospital for Sick Children | ||
| Full Title: Intensified pre-operative chemotherapy and radical surgery for HIGH RISK HEPATOBLASTOMA SIOPEL 4 | ||
| Medical condition: Hepatoblastoma | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: IE (Completed) BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002434-38 | Sponsor Protocol Number: 197319731973 | Start Date*: 2006-07-14 |
| Sponsor Name:Dr catenacci fabrice/ quartier operatoire | ||
| Full Title: BLOC DU PLEXUS LOMBOSACRE PAR VOIE PARAVERTEBRALE : EVA-LUATION POUR LA PRATIQUE QUOTIDIENNNE | ||
| Medical condition: Nous évaluons une technique d’anesthésie locorégionale permettant la réalisation d’une anesthésie du membre inférieur pour les chirurgies de la hanche au pied. Par une seule ponction transcutanée p... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-005017-23 | Sponsor Protocol Number: FM-14-B02 | Start Date*: 2016-01-26 | ||||||||||||||||||||||||||||||||||||
| Sponsor Name:Fondazione Michelangelo - Avanzamento dello studio e cura dei tumori | ||||||||||||||||||||||||||||||||||||||
| Full Title: Neo-Adjuvant study with the PDL1-directed antibody in Triple Negative, Early High-Risk and Locally Advanced Breast Cancer undergoing treatment with nab-paclitaxel and carboplatin | ||||||||||||||||||||||||||||||||||||||
| Medical condition: Women with a diagnosis of invasive unilateral, early high-risk and locally advanced or inflammatory, triple negative (HER2-negative and ER-negative and PgRnegative) breast cancer of high proliferat... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||||||||||||
| Trial protocol: DE (Completed) AT (Completed) ES (Completed) IE (Completed) IT (Completed) | ||||||||||||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2007-004406-26 | Sponsor Protocol Number: A/100/0402 | Start Date*: 2007-11-26 |
| Sponsor Name:AVAX Technologies Inc. | ||
| Full Title: Comparison of M-Vax plus Low Dose Interleukin-2 versus Placebo Vaccine plus Low Dose Interleukin-2 in patients with Stage IV Melanoma | ||
| Medical condition: Melanoma Stage IV MedDRA : 10025671 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-004034-11 | Sponsor Protocol Number: GR-OG-279239-04 | Start Date*: 2022-05-18 | ||||||||||||||||
| Sponsor Name:Genera Research Ltd | ||||||||||||||||||
| Full Title: A randomized, evaluator-blinded, dose-ranging, proof of concept study of efficacy, safety and tolerability of Osteogrow-C (rhBMP6 delivered in autologous blood coagulum [ABC] supplemented with sy... | ||||||||||||||||||
| Medical condition: The treatment of non-union of the tibia | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: AT (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2007-003223-20 | Sponsor Protocol Number: TEMO-PK6 | Start Date*: 2007-08-01 | ||||||||||||||||
| Sponsor Name:Cliniques Universitaires St Luc - UCL | ||||||||||||||||||
| Full Title: Temocillin use in intensive care units: A Pharmacokinetic study of 6g per day in conventional administration vs. continuous infusion | ||||||||||||||||||
| Medical condition: Patients will be eligible for participation in the study if they : 1. are hospitalized in an intensive care unit 2. have an abdominal or a pulmonary infection | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: BE (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2008-004869-25 | Sponsor Protocol Number: GORTEC 2008-03 | Start Date*: 2008-12-31 |
| Sponsor Name:Groupe d'Oncologie Radiothérapie Tête Et Cou (GORTEC) | ||
| Full Title: Étude de phase II évaluant l’association cetuximab, docétaxel et cisplatine en première ligne de traitement des carcinomes épidermoïdes de la tête et du cou métastatiques ou récidivants | ||
| Medical condition: L’addition de cetuximab au docétaxel et au cisplatine dans le traitement des cancers ORL métastatiques ou récidivants se justifie par la mortalité encore importante dans cette indication, les donné... | ||
| Disease: | ||
| Population Age: | Gender: Male, Female | |
| Trial protocol: FR (Completed) BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-004193-18 | Sponsor Protocol Number: LEVOS-001 | Start Date*: 2017-02-16 |
| Sponsor Name:Semmelweis University, Heart and Vascular Center | ||
| Full Title: Effect of repetitive levosimendan treatment on clinical outcomes of chronic heart failure patients: focus on optimal patient selection based on novel cardiac biomarkers. | ||
| Medical condition: A total of 80 symptomatic patients with severe ischaemic or non-ischaemic cardiomyopathy will be enrolled in the study. Those, who were implanted a device and proved to be non-responders or low res... | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-006558-17 | Sponsor Protocol Number: | Start Date*: 2010-01-21 |
| Sponsor Name:cliniques universitaire de mont godinne | ||
| Full Title: | ||
| Medical condition: major depression | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-004144-22 | Sponsor Protocol Number: BORLEUWT01 | Start Date*: 2012-01-12 |
| Sponsor Name:Institut Jules Bordet - Université Libre de Bruxelles | ||
| Full Title: A Phase I/II study to assess the safety and immunogenicity of WT1-A10 + AS01B Antigen-Specific Cancer Immunotherapeutic (ASCI) combined with infusions of ex vivo regulatory T cells depleted T lymph... | ||
| Medical condition: For adult patients with WT1-positive Acute Myeloid Leukemia (AML) in CR1 (for high risk patients) or in CR2 or CR3 who are not eligible for allogeneic stem cell transplantation (SCT) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-005474-38 | Sponsor Protocol Number: YZIRIT | Start Date*: 2012-03-08 | |||||||||||
| Sponsor Name:Institut Jules Bordet | |||||||||||||
| Full Title: 89Zr-Rituximab PET/CT-Imaging and Dosimetry and 90Y-Rituximab Radioimmunotherapy in CD20+ B-Cell lymphoma | |||||||||||||
| Medical condition: CD20 positive Lymphoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-002673-21 | Sponsor Protocol Number: 35RC17_8841_EFFICACI | Start Date*: 2018-09-04 | |||||||||||
| Sponsor Name:Centre Hospitalier Universitaire de Rennes | |||||||||||||
| Full Title: EFFICACI : EFFicacy of intravenous Infliximab versus vedolizumab after failure of subCutaneous Anti-TNF in patients with UlCerative colitis : A double blinded Randomized Clinical Trial. | |||||||||||||
| Medical condition: Ulcerative colitis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2011-004410-42 | Sponsor Protocol Number: C11-09 | Start Date*: 2012-11-26 | |||||||||||||||||||||
| Sponsor Name:Inserm | |||||||||||||||||||||||
| Full Title: A phase I/II, open labeled, monocentric study of direct intracranial administration of a replication deficient adeno-associated virus gene transfer vector serotype rh.10 expressing the human ARSA c... | |||||||||||||||||||||||
| Medical condition: Early onset forms of MLD | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
